Rainer Blasczyk

from Wikipedia, the free encyclopedia
Rainer Blasczyk

Rainer Blasczyk (born January 8, 1962 in Castrop-Rauxel ) is a German transfusion specialist specializing in histocompatibility and immunogenetics in the field of organ transplantation . He is known for developing transplant engineering to prevent organ rejection .

Life

Rainer Blasczyk has been a university professor at the Hannover Medical School since 1998, where he is director of the Institute for Transfusion Medicine and Transplant Engineering. Blasczyk completed his medical studies at the University of Essen in 1987 and began his clinical training in visceral surgery at the University of Marburg , where his interest in organ transplantation arose. In 1988 he moved to the Institute for Immunology at the University of Essen to study the field of histocompatibility and immunogenetics. From 1991 to 1993 he continued his clinical training in hematology and oncology at the University of Düsseldorf . After these clinical years, he returned to the field of immunology at the Institute for Transfusion Medicine at the Humboldt University in Berlin in 1993, where he began his work on molecular immunogenetics. After his appointment in his current position, he initiated research into transplant engineering.

Blasczyk was president of the German Society for Immunogenetics (DGI) from 2006 to 2008 and 2012-2014 , from 2015 to 2016 President of the German Society for Transfusion Medicine and Immunohematology (DGTI), from 2008 to 2010 board member of the European Federation for Immunogenetics (EFI) and from 2009 to 2019 as a transplant specialist on the scientific advisory board. Blasczyk is editor of the journal Transfusionsmedizin and a member of the editorial board of HLA. From 2016 to 2019 he was an appointed member of the Blood Working Group of the Federal Ministry of Health .

plant

Blasczyk's research focuses on the immune response in transplants and strategies for combating organ rejection. Together with Constanca Figueiredo, he initiated research on transplant engineering by genetically modifying allografts so that they are invisible to the recipient's immune system and are not rejected. Since 2018, Blasczyk has headed the research consortium for Invisible Organs, an innovation network that is jointly financed by the European Regional Development Fund and the State of Lower Saxony .

Publications

Individual evidence

  1. Hannover Medical School: Institute for Transfusion Medicine and Transplant Engineering. Retrieved December 10, 2019 .
  2. Prof. Dr. Rainer Blasczyk, MD - Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School - Director / Prof. Dr. Retrieved December 10, 2019 .
  3. Board of Directors. Retrieved October 15, 2019 .
  4. Scientific Committee | EFIweb. Retrieved October 15, 2019 .
  5. ^ Editor / Advisory Board - Georg Thieme Verlag - Transfusion Medicine. Retrieved October 15, 2019 (German).
  6. HLA. Retrieved October 15, 2019 .
  7. ^ RKI - List of the members of the working group blood. Retrieved October 15, 2019 .
  8. Constança Figueiredo, Dirk Wedekind, Thomas Müller, Stefanie Vahlsing, Peter A. Horn: MHC Universal Cells Survive in an Allogeneic Environment after Incompatible Transplantation . In: BioMed Research International . tape 2013 , 2013, ISSN  2314-6133 , pp. 1–12 , doi : 10.1155 / 2013/796046 ( hindawi.com [accessed October 15, 2019]).
  9. Bettina Wiegmann, Constança Figueiredo, Christiane Gras, Michael Pflaum, Sabrina Schmeckebier: Prevention of rejection of allogeneic endothelial cells in a biohybrid lung by silencing HLA-class I expression . In: Biomaterials . tape 35 , no. 28 , September 1, 2014, ISSN  0142-9612 , p. 8123–8133 , doi : 10.1016 / j.biomaterials.2014.06.007 ( sciencedirect.com [accessed October 15, 2019]).
  10. Constanca Figueiredo, Marco Carvalho Oliveira, Chen Chen-Wacker, Katharina Jansson, Klaus Höffler: Immunoengineering of the Vascular Endothelium to Silence MHC Expression During Normothermic Ex Vivo Lung Perfusion . In: Human Gene Therapy . tape 30 , no. 4 , April 2019, ISSN  1043-0342 , p. 485–496 , doi : 10.1089 / hum.2018.117 ( liebertpub.com [accessed October 15, 2019]).
  11. New ways in transplant medicine with Invisible Organs. Retrieved October 15, 2019 .